US 12246059
Stable hybrid FC fusion G-CSF formulation
granted A61KA61K38/193A61K47/02
Quick answer
US patent 12246059 (Stable hybrid FC fusion G-CSF formulation) held by ILKOGEN ILAÇ SANAYI VE TICARET A.S. expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ILKOGEN ILAÇ SANAYI VE TICARET A.S.
- Grant date
- Tue Mar 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K38/193, A61K47/02, A61K47/10, A61K9/0019